12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's after-market session, several health care stocks showed significant movement. OneMedNet (ONMD) led the gainers with a 75.9% increase, while Enveric Biosciences (ENVB) experienced the largest drop among the losers, decreasing by 14.1%. Notably, companies like GlycoMimetics (GLYC), Acorda Therapeutics (ACOR), and Imunon (IMNN) had recent earnings reports influencing their stock movements.
April 02, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Acorda Therapeutics stock fell 12.0% after its Q4 earnings report was released yesterday.
The decline in ACOR's stock price indicates a negative market reaction to its recent Q4 earnings report.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Enveric Biosciences stock decreased by 14.1%, marking it as the largest loser in the session.
The significant drop in ENVB's stock price suggests negative sentiment or disappointing developments for the company.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Imunon shares declined by 7.43% after its Q4 earnings were announced three days ago.
The decrease in IMNN's stock price post-earnings suggests the results did not meet market expectations.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
GlycoMimetics stock rose 6.41% following its Q4 earnings report released four days ago.
The positive movement in GLYC's stock price post-earnings suggests the report was received favorably by the market.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
OneMedNet shares surged 75.9% in after-market trading, with a market value of $44.8 million.
The substantial increase in ONMD's stock price indicates strong investor interest, potentially due to positive developments or expectations.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90